¾ÆÇÁ¸®Ä«ÀÇ Ç×¾ÏÁ¦ ½ÃÀå ±Ô¸ð ¹× ¿¹Ãø(2021-2031³â), Áö¿ª Á¡À¯À², µ¿Çâ, ¼ºÀå ±âȸ ºÐ¼® º¸°í¼­ : ¾à¹° Á¾·ùº°, ÀûÀÀÁõº°, Á¦Çüº°, Ä¡·á¹ýº°, ºÎ¹®º°, ±¹°¡º°
Africa Anticancer Drugs Market Size and Forecast 2021 - 2031, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Drug Class, Indication, Dosage Form, Therapy, Sector, and Country
»óǰÄÚµå : 1761149
¸®¼­Ä¡»ç : The Insight Partners
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 315 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,450 £Ü 4,758,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.
US $ 4,450 £Ü 6,137,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,450 £Ü 7,516,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¾ÆÇÁ¸®Ä«ÀÇ Ç×¾ÏÁ¦ ½ÃÀå ±Ô¸ð´Â 2024³â 18¾ï 1,000¸¸ ´Þ·¯¿¡¼­ 2031³â 32¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ ½ÃÀåÀº 2025-2031³â CAGR 8.8%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

º» º¸°í¼­ÀÇ ¾ÆÇÁ¸®Ä« Ç×¾ÏÁ¦ ½ÃÀå ¿¹ÃøÀº ÇØ´ç ½ÃÀå °ø°£ÀÇ ÀÌÇØ°ü°èÀÚµéÀÌ ¼ºÀå Àü·«À» ¼ö¸³ÇÏ´Â µ¥ µµ¿òÀÌ µÉ °ÍÀÔ´Ï´Ù. ¾Ï ¹ßº´·üÀÇ Áõ°¡¿Í ¾Ï¿¡ ´ëÇÑ ÀνÄÀ» °³¼±Çϱâ À§ÇÑ ÀÌ´Ï¼ÅÆ¼ºêÀÇ ±ÞÁõÀº ¾ÆÇÁ¸®Ä« Ç×¾ÏÁ¦ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

¾Ï Ä¡·á¸¦ °¡¼ÓÈ­ÇÏ´Â ÀΰøÁö´É

ÀΰøÁö´É(AI)Àº Ç×¾ÏÁ¦ ½ÃÀå¿¡¼­ À¯ÀüÀÚ ´Ù¾ç¼º, ÀÓ»ó µ¥ÀÌÅÍ ºÎÁ·, °³ÀÎÈ­µÈ Ä¡·á Á¢±Ù¼º Á¦ÇѰú °ü·ÃµÈ ½É°¢ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇÑ Çõ½ÅÀÇ ÈûÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î ¾Ï ȯÀÚ°¡ Å©°Ô Áõ°¡ÇÔ¿¡ µû¶ó AI´Â ½Å¾à °³¹ßÀ» °¡¼ÓÈ­Çϰí, Ä¡·á¸¦ ÃÖÀûÈ­Çϸç, Áö¿ª Çõ½ÅÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¾Ï °ËÁø, Áø´Ü ¹× Ä¡·á¿¡ AI¸¦ Àû¿ëÇÏ¸é ¾ÏÀ» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ´Â ±æÀÌ ¿­¸®°í, ȯÀÚ °³°³Àο¡ ¸Â´Â »õ·Î¿î Ä¡·á °èȹÀÇ °³¹ßÀÌ °¡¼ÓÈ­µÉ ¼ö ÀÖ½À´Ï´Ù.

ÄÉÀÌÇÁŸ¿î ´ëÇб³, ±Û¶ô¼Ò ½º¹Ì½ºÅ¬¶óÀÎ, ³ë¹ÙƼ½º, ³²¾ÆÇÁ¸®Ä«°øÈ­±¹ ÀÇÇבּ¸À§¿øÈ¸°¡ Çù·ÂÇÏ´Â ÇÁ·ÎÁ§Æ® ¾ÆÇÁ¸®Ä« GRADIENT´Â ¾ÆÇÁ¸®Ä«ÀÇ À¯ÀüÀÚ ÇÁ·ÎÆÄÀÏ¿¡ ¸Â°Ô ¾à¹°À» Á¶Á¤ÇÏ´Â µ¥ ÀÖ¾î AIÀÇ ¿ªÇÒÀ» ¿¹½ÃÇϰí ÀÖ½À´Ï´Ù. ÀÌ ÀÌ´Ï¼ÅÆ¼ºê´Â ¾à¹° ¹ÝÀÀ¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â À¯ÀüÀû µ¹¿¬º¯À̸¦ °í·ÁÇÔÀ¸·Î½á ¾ÆÇÁ¸®Ä« »ç¶÷µéÀ» À§ÇØ ¼³°èµÈ Ä¡·á¹ýÀÇ È¿´ÉÀ» Çâ»ó½ÃŰ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀº Ä¡·á°¡ ´õ È¿°úÀûÀÌ°í ºÎÀÛ¿ëÀÌ ÀûÀ¸¸ç ȯÀÚÀÇ °á°ú¸¦ Å©°Ô °³¼±ÇÒ ¼ö ÀÖµµ·Ï º¸ÀåÇÕ´Ï´Ù. ¶ÇÇÑ AI´Â ¹æ´ëÇÑ ¾çÀÇ »ý¹°ÇÐÀû µ¥ÀÌÅ͸¦ ºÐ¼®ÇÏ¿© ÀáÀçÀûÀÎ ¾à¹° È常¦ ½Äº°ÇÔÀ¸·Î½á ½Å¾à °³¹ß °úÁ¤À» °¡¼ÓÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀνǸ®ÄÚ ¸Þµð½Å(Insilico Medicine)°ú °°Àº °³¹ß¾÷üµéÀº ÀúºÐÀÚ Ä¡·á¹ýÀ» ¼³°èÇÏ°í ½Å¾à Ÿ°ÙÀ» ¹ß°ßÇϱâ À§ÇØ AI ±â¹Ý Ç÷§ÆûÀ» äÅÃÇÏ¿© ÀǾàǰ °³¹ß ±â°£À» ¼ö³â¿¡¼­ ¼ö°³¿ù·Î ´ÜÃàÇϰí ÀÖ½À´Ï´Ù. 2023³â 4¿ù, ¼¼°è Á¦¾à»ç ¾Æ½ºÆ®¶óÁ¦³×Ä«(AstraZeneca)´Â ³²¾ÆÇÁ¸®Ä«°øÈ­±¹ÀÇ ÀÇ·á ±â¼ú ±â¾÷ MedSol AI Solutions¿Í ¼ÕÀâ°í À¯¹æ¾Ï ¹ß°ß¿¡ AI¸¦ Ȱ¿ëÇϱâ À§ÇØ Çù·ÂÇϱâ·Î Çß½À´Ï´Ù. ¾ç»çÀÇ Çù·ÂÀÇ ÇÙ½ÉÀº ¸î ÃÊ ¾È¿¡ À¯¹æ¾ÏÀ» ½Äº°ÇÒ ¼ö ÀÖ´Â ÃÖ÷´Ü Wi-Fi Áö¿ø ÃÊÀ½ÆÄ ŽħÀÔ´Ï´Ù. ƯÈ÷ ¼Ò¿ÜµÈ Áö¿ªÀÇ Á¶±â Áø´ÜÀ» µ½±â À§ÇØ Áö¹æ Áø·á¼Ò¿¡ Melusi Breast AI Rapid Detection ¾ÛÀÌ ¹èÆ÷µÉ ¿¹Á¤ÀÔ´Ï´Ù. Àü¿ë ÀÇ·Ú ½Ã½ºÅÛÀÌ ÀÌ ÀÌ´Ï¼ÅÆ¼ºê¸¦ µÞ¹ÞħÇÏ¿© ¾ç¼º ÆÇÁ¤À» ¹ÞÀº ¿©¼ºµéÀÌ Àû½Ã¿¡ Ä¡·á¸¦ ¹ÞÀ» ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ÀÌó·³ ¾ÆÇÁ¸®Ä«ÀÇ ¾Ï Ä¡·á¿¡ AI¸¦ ÅëÇÕÇϸé Ä¡·á °á°ú¸¦ °³¼±Çϰí ÀÇÇÐ ¿¬±¸ ¹× °³¹ßÀÇ ÀÚ¸³À» ÃËÁøÇÒ ¼ö ÀÖÀ¸¸ç, AI¸¦ Ȱ¿ëÇÏ¸é ¾ÆÇÁ¸®Ä« ±¹°¡µéÀº À¯ÀüÀû ´Ù¾ç¼º°ú °³º°È­µÈ Ä¡·á¿¡ ´ëÇÑ Á¦ÇÑµÈ Á¢±ÙÀ¸·Î ÀÎÇÑ °íÀ¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇÏ°í º¸´Ù °øÆòÇÑ ÀÇ·á ¼Ö·ç¼ÇÀ¸·Î °¡´Â ±æÀ» ¿­ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ AI´Â ¸ÂÃãÇü Ä¡·á¸¦ °¡´ÉÇÏ°Ô Çϰí, ÀǾàǰ °³¹ßÀ» °¡¼ÓÈ­Çϸç, Á¾ÇÕÀûÀÎ ¿¬±¸¸¦ ÃËÁøÇÔÀ¸·Î½á ¾ÆÇÁ¸®Ä«ÀÇ Ç×¾ÏÁ¦ ½ÃÀå¿¡ »õ·Î¿î Æ®·»µå¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù.

¾àÁ¦ Á¾·ùº°·Î ¾ÆÇÁ¸®Ä« Ç×¾ÏÁ¦ ½ÃÀåÀº ¼¼Æ÷µ¶¼º ¾à¹°, Ç¥Àû Ä¡·áÁ¦, È£¸£¸óÁ¦, ¸é¿ªÄ¡·áÁ¦, À¯ÀüÀÚ Ä¡·áÁ¦, ¹æ»ç¼ºÀǾàǰ, ±âŸ·Î ºÐ·ùµË´Ï´Ù. ¼¼Æ÷µ¶¼º ÀǾàǰ ºÎ¹®Àº 2024³â °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù. Ç¥Àû Ä¡·áÁ¦ ºÎ¹®Àº 2025-2031³â °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀûÀÀÁõº°·Î ¾ÆÇÁ¸®Ä« Ç×¾ÏÁ¦ ½ÃÀåÀº Æó¾Ï, À§¾Ï, ´ëÀå¾Ï, À¯¹æ¾Ï, Àü¸³¼±¾Ï, ±âŸ·Î ºÐ·ùµË´Ï´Ù. Æó¾Ï ºÎ¹®Àº 2024³â¿¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, À¯¹æ¾Ï ºÎ¹®Àº 2025-2031³â µ¿¾È ½ÃÀå¿¡¼­ °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

Ä¡·á¹ýº°·Î ¾ÆÇÁ¸®Ä« Ç×¾ÏÁ¦ ½ÃÀåÀº È­Çпä¹ý, Ç¥Àû Ä¡·áÁ¦, ¸é¿ªÄ¡·áÁ¦, À¯ÀüÀÚ Ä¡·áÁ¦, ¹æ»ç¼ºÀǾàǰġ·áÁ¦, ±âŸ·Î ºÐ·ùµË´Ï´Ù. È­Çпä¹ý ºÎ¹®Àº 2024³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, 2025-2031³â µ¿¾È °¡Àå ³ôÀº CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

Á¦Çüº°·Î ¾ÆÇÁ¸®Ä« Ç×¾ÏÁ¦ ½ÃÀåÀº Á¤Á¦ ¹× ĸ½¶, ÁÖ»çÁ¦, ¾×Á¦·Î ºÐ·ùµË´Ï´Ù. Á¤Á¦ ¹× ĸ½¶Á¦´Â 2024³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, 2025-2031³â ½ÃÀå CAGRÀÌ °¡Àå ³ôÀ» °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

ºÎ¹®º°·Î´Â °ø°ø°ú ¹Î°£ ºÎ¹®À¸·Î ³ª´µ¸ç, 2024³â ½ÃÀå ±Ô¸ð¿¡¼­ °ø°ø ºÎ¹®ÀÌ Å« ºñÁßÀ» Â÷ÁöÇß°í, 2025-2031³â CAGRÀº ¹Î°£ ºÎ¹®ÀÌ ´õ ³ôÀ» °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

º» º¸°í¼­ ÀÛ¼º¿¡ Âü°íÇÑ ÁÖ¿ä 1Â÷ ¹× 2Â÷ Á¤º¸´Â GLOBOCAN-IARC, WHO Cancer Country Profiles, WHO Global Health Observatory, UN Comtrade Database, IAEA DIRAC, World Bank, WHO Global Health Expenditure Database, Ministries of Health (e.g., Egypt CAPA, Nigeria NHIS), African Medicines Agency (AMA), BMI Fitch)ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¾ÆÇÁ¸®Ä«ÀÇ Ç×¾ÏÁ¦ ½ÃÀå »óȲ

Á¦5Àå ¾ÆÇÁ¸®Ä«ÀÇ Ç×¾ÏÁ¦ ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ

Á¦6Àå ¾ÆÇÁ¸®Ä«ÀÇ Ç×¾ÏÁ¦ ½ÃÀå : ½ÃÀå ºÐ¼®

Á¦7Àå ¾ÆÇÁ¸®Ä«ÀÇ Ç×¾ÏÁ¦ ½ÃÀå ºÐ¼® : ¾à¹° Á¾·ùº°

Á¦8Àå ¾ÆÇÁ¸®Ä«ÀÇ Ç×¾ÏÁ¦ ½ÃÀå ºÐ¼® : ÀûÀÀÁõº°

Á¦9Àå ¾ÆÇÁ¸®Ä«ÀÇ Ç×¾ÏÁ¦ ½ÃÀå ºÐ¼® : Á¦Çüº°

Á¦10Àå ¾ÆÇÁ¸®Ä«ÀÇ Ç×¾ÏÁ¦ ½ÃÀå ºÐ¼® : Ä¡·á¹ýº°

Á¦11Àå ¾ÆÇÁ¸®Ä«ÀÇ Ç×¾ÏÁ¦ ½ÃÀå ºÐ¼® : ºÎ¹®º°

Á¦12Àå ¾ÆÇÁ¸®Ä«ÀÇ Ç×¾ÏÁ¦ ½ÃÀå : Áö¿ªº° ºÐ¼®

Á¦13Àå °æÀï ±¸µµ

Á¦14Àå ¾÷°è »óȲ

Á¦15Àå ±â¾÷ °³¿ä

Á¦16Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The Africa anticancer drugs market is expected to reach US$ 3.23 billion by 2031 from US$ 1.81 billion in 2024. The market is estimated to grow with a CAGR of 8.8% from 2025 to 2031.

The Africa anticancer drugs market forecast presented in this report can help stakeholders in this marketplace plan their growth strategies. The increasing incidence of cancer and surging initiatives to improve cancer awareness are the key factors propelling the Africa anticancer drugs market growth.

Artificial Intelligence Accelerating Cancer Care

Artificial Intelligence (AI) is emerging as a transformative force in the anticancer drugs market, addressing critical challenges associated with genetic diversity, scarce clinical data, and limited access to personalized treatments. Amid the vast increase in cancer cases across the continent, AI is accelerating drug discovery, optimizing treatments, and fostering local innovation. The practical application of AI in cancer screening, diagnosis, and care opens the door for early cancer identification and accelerates the development of new treatment plans tailored to each patient.

Project Africa GRADIENT, a collaboration between the University of Cape Town, GlaxoSmithKline, Novartis, and the South African Medical Research Council, exemplifies AI's role in tailoring drugs to African genetic profiles. This initiative aims to enhance the efficacy of treatments designed for African populations by considering genetic variations that influence drug responses. This approach ensures that therapies are more effective and have fewer side effects, significantly improving patient outcomes. Additionally, AI accelerates the drug discovery process by analyzing vast amounts of biological data to identify potential drug candidates. Companies such as Insilico Medicine employ AI-driven platforms to design small-molecule treatments and discover drug targets, reducing drug development timelines from years to months. This rapid development is crucial for addressing the increasing cancer burden in Africa, where early detection and treatment options are often limited. In April 2023, AstraZeneca (a global pharmaceutical company) joined forces with South African health-tech firm MedSol AI Solutions to advance the use of AI in breast cancer detection. Their collaboration centers around a cutting-edge Wi-Fi-enabled ultrasound probe capable of identifying breast cancer within seconds. Their Melusi Breast AI rapid detection app will be deployed in rural clinics to support early diagnosis, particularly in underserved areas. A dedicated referral system backs the initiative to ensure that women with positive results can access timely therapeutic interventions. Thus, AI integration into the cancer care landscape in Africa would enhance treatment outcomes and promote self-reliance in medical research and development. By harnessing AI, African nations can address the unique challenges posed by genetic diversity and limited access to personalized care, paving the way for more equitable healthcare solutions. Hence, by enabling personalized treatments, accelerating drug development, and fostering inclusive research, AI is setting new trends in the Africa anticancer drugs market.

Based on drug class, the Africa anticancer drugs market is segmented into cytotoxic drugs, targeted drugs, hormonal drugs, immunotherapy drugs, gene therapy drugs, radiopharmaceuticals, and others. The cytotoxic drugs segment held the largest share in 2024. The targeted drugs segment is expected to register the highest CAGR during 2025-2031.

Based on indication, the Africa anticancer drugs market is segmented into lung cancer, stomach cancer, colorectal cancer, breast cancer, prostate cancer, and others. The lung cancer segment held the largest market share in 2024, and the breast cancer segment is estimated to register the highest CAGR in the market during 2025-2031.

In terms of therapy type, the Africa anticancer drugs market is categorized into chemotherapy, targeted therapy, immunotherapy, gene therapy, radiopharmaceutical therapy, and others. The chemotherapy segment held the largest market share in 2024, and the same segment is estimated to register the highest CAGR in the market during 2025-2031.

Based on dosage form, the Africa anticancer drugs market is categorized into tablet and capsule, injectable, and liquid. The tablet and capsule segment held the largest market share in 2024, and the same segment is estimated to register the highest CAGR in the market during 2025-2031.

By sector, the market is bifurcated into public and private. The public segment held a larger share of the market in 2024. The private segment is estimated to register a higher CAGR during 2025-2031.

A few of the major primary and secondary sources referred to while preparing the report on the Africa anticancer drugs market are the GLOBOCAN - IARC, WHO Cancer Country Profiles, WHO Global Health Observatory, UN Comtrade Database, IAEA DIRAC, World Bank, WHO Global Health Expenditure Database, Ministries of Health (e.g., Egypt CAPA, Nigeria NHIS), African Medicines Agency (AMA), BMI Fitch).

Table Of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. African Anticancer Drugs Market Landscape

5. African Anticancer Drugs Market - Key Market Dynamics

6. African Anticancer Drugs Market - Global Market Analysis

7. African Anticancer Drugs Market Analysis - by Drug Class Type

8. African Anticancer Drugs Market Analysis - by Indication

9. African Anticancer Drugs Market Analysis - by Dosage Form

10. African Anticancer Drugs Market Analysis - by Therapy

11. African Anticancer Drugs Market Analysis - by Sector

12. African Anticancer Drugs Market - Geographical Analysis

13. Competitive Landscape

14. Industry Landscape

15. Company Profiles

16. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â